This announcement is a separate document:
信立泰：关于受让“重组SeV-hFGF2/dF注射液”有关使用权的公告
Xinlitai: Announcement on the transfer of usage rights for “recombinant sev-HFGF2/DF injection”
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.